A new era of cancer immunotherapy: converting theory to performance

CA Cancer J Clin. 1999 Mar-Apr;49(2):70-3, 65. doi: 10.3322/canjclin.49.2.70.

Abstract

The major impact of recent scientific advances, such as the discovery of genes and gene products, has been to facilitate development of immunotherapies based on the specific stimulation of immune reactions against characterized tumor antigens.

Publication types

  • Editorial

MeSH terms

  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / therapeutic use
  • Humans
  • Immunotherapy*
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / therapy
  • Melanoma / therapy
  • Neoplasms / immunology
  • Neoplasms / therapy*

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Interleukin-2